Ethical Minefields and Financial Woes Sink Designer Baby Startups

The collapse of Manhattan Genomics and Bootstrap Bio highlights the massive financial and ethical barriers facing germline editing ventures. These failures underscore how legal prohibitions and reputational scandals can swiftly derail businesses aiming to commercialize controversial human enhancements.